HC Wainwright & Co. Maintains Buy on Curis, Lowers Price Target to $6

Benzinga · 21h ago
HC Wainwright & Co. analyst Sara Nik maintains Curis (NASDAQ:CRIS) with a Buy and lowers the price target from $43 to $6.